195 related articles for article (PubMed ID: 16495921)
1. Cyclin D1 A870G polymorphism and the risk of colorectal cancer and adenoma.
Schernhammer ES; Tranah GJ; Giovannucci E; Chan AT; Ma J; Colditz GA; Hunter DJ; Willett WC; Fuchs CS
Br J Cancer; 2006 Mar; 94(6):928-34. PubMed ID: 16495921
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 A870G polymorphism in Brazilian colorectal cancer patients.
Forones NM; de Lima JM; de Souza LG; da Silva ID
J Gastrointest Cancer; 2008; 39(1-4):118-23. PubMed ID: 19373442
[TBL] [Abstract][Full Text] [Related]
3. Polymorphism of the cyclin D1 gene, CCND1, and risk for incident sporadic colorectal adenomas.
Lewis RC; Bostick RM; Xie D; Deng Z; Wargovich MJ; Fina MF; Roufail WM; Geisinger KR
Cancer Res; 2003 Dec; 63(23):8549-53. PubMed ID: 14679024
[TBL] [Abstract][Full Text] [Related]
4. Association of cyclin D1 genotype with breast cancer risk and survival.
Shu XO; Moore DB; Cai Q; Cheng J; Wen W; Pierce L; Cai H; Gao YT; Zheng W
Cancer Epidemiol Biomarkers Prev; 2005 Jan; 14(1):91-7. PubMed ID: 15668481
[TBL] [Abstract][Full Text] [Related]
5. The influence of cyclin D1 A870G polymorphism on colorectal cancer risk and prognosis in a Turkish population.
Yaylim-Eraltan I; Arikan S; Yildiz Y; Cacina C; Ergen HA; Tuna G; Görmüs U; Zeybek U; Isbir T
Anticancer Res; 2010 Jul; 30(7):2875-80. PubMed ID: 20683026
[TBL] [Abstract][Full Text] [Related]
6. APC Asp1822Val and Gly2502Ser polymorphisms and risk of colorectal cancer and adenoma.
Tranah GJ; Giovannucci E; Ma J; Fuchs C; Hunter DJ
Cancer Epidemiol Biomarkers Prev; 2005 Apr; 14(4):863-70. PubMed ID: 15824157
[TBL] [Abstract][Full Text] [Related]
7. The effect of the cyclin D1 (CCND1) A870G polymorphism on colorectal cancer risk is modified by glutathione-S-transferase polymorphisms and isothiocyanate intake in the Singapore Chinese Health Study.
Probst-Hensch NM; Sun CL; Van Den Berg D; Ceschi M; Koh WP; Yu MC
Carcinogenesis; 2006 Dec; 27(12):2475-82. PubMed ID: 16829689
[TBL] [Abstract][Full Text] [Related]
8. Association of the cyclin D1 A870G polymorphism with advanced colorectal cancer.
Le Marchand L; Seifried A; Lum-Jones A; Donlon T; Wilkens LR
JAMA; 2003 Dec; 290(21):2843-8. PubMed ID: 14657069
[TBL] [Abstract][Full Text] [Related]
9. Cyclin D1 protein expression and gene polymorphism in colorectal cancer. Aberdeen Colorectal Initiative.
McKay JA; Douglas JJ; Ross VG; Curran S; Murray GI; Cassidy J; McLeod HL
Int J Cancer; 2000 Oct; 88(1):77-81. PubMed ID: 10964085
[TBL] [Abstract][Full Text] [Related]
10. The significant association of CCND1 genotypes with colorectal cancer in Taiwan.
Huang CY; Tsai CW; Hsu CM; Chang WS; Shui HA; Bau DT
Tumour Biol; 2015 Aug; 36(8):6533-40. PubMed ID: 25809706
[TBL] [Abstract][Full Text] [Related]
11. Impact of the cyclin D1 A870G polymorphism on susceptibility to sporadic colorectal cancer in Taiwan.
Huang WS; Tang R; Lin PY; Changchien CR; Chen JS; Chiang JM; Yeh CY; Wang JY; Hsieh LL
Dis Colon Rectum; 2006 May; 49(5):602-8. PubMed ID: 16552496
[TBL] [Abstract][Full Text] [Related]
12. Relationship between cyclin D1 (A870G) gene polymorphism and lung cancer.
Cakina S; Gulyasar T; Ozen A; Sipahi T; Kocak Z; Sener S
Indian J Biochem Biophys; 2013 Jun; 50(3):233-6. PubMed ID: 23898488
[TBL] [Abstract][Full Text] [Related]
13. Cyclin D1 gene polymorphism and familial prostate cancer: the AA genotype of A870G polymorphism is associated with prostate cancer risk in men aged 70 years or older and metastatic stage.
Koike H; Suzuki K; Satoh T; Ohtake N; Takei T; Nakata S; Yamanaka H
Anticancer Res; 2003; 23(6D):4947-51. PubMed ID: 14981950
[TBL] [Abstract][Full Text] [Related]
14. Increased risk of prostate cancer associated with AA genotype of cyclin D1 gene A870G polymorphism.
Wang L; Habuchi T; Mitsumori K; Li Z; Kamoto T; Kinoshita H; Tsuchiya N; Sato K; Ohyama C; Nakamura A; Ogawa O; Kato T
Int J Cancer; 2003 Jan; 103(1):116-20. PubMed ID: 12455063
[TBL] [Abstract][Full Text] [Related]
15. CCND1 polymorphisms (A870G and C1722G) modulate its protein expression and survival in oral carcinoma.
Sathyan KM; Nalinakumari KR; Abraham T; Kannan S
Oral Oncol; 2008 Jul; 44(7):689-97. PubMed ID: 18061526
[TBL] [Abstract][Full Text] [Related]
16. Increased risk of cervical cancer associated with cyclin D1 gene A870G polymorphism.
Catarino R; Matos A; Pinto D; Pereira D; Craveiro R; Vasconcelos A; Lopes C; Medeiros R
Cancer Genet Cytogenet; 2005 Jul; 160(1):49-54. PubMed ID: 15949570
[TBL] [Abstract][Full Text] [Related]
17. An alternative cyclin-D1 splice site is not linked to inflammatory bowel disease-associated neoplasia.
Kanaan Z; Eichenberger MR; Young M; Colliver D; Crawford N; Cobbs GA; Hein DW; Galandiuk S
Int J Biol Markers; 2010; 25(1):27-31. PubMed ID: 20306448
[TBL] [Abstract][Full Text] [Related]
18. The significant association of CCND1 genotypes with gastric cancer in Taiwan.
Kuo HW; Huang CY; Fu CK; Liao CH; Hsieh YH; Hsu CM; Tsai CW; Chang WS; Bau DT
Anticancer Res; 2014 Sep; 34(9):4963-8. PubMed ID: 25202078
[TBL] [Abstract][Full Text] [Related]
19. Cyclin D1 (CCND1) A870G gene polymorphism modulates smoking-induced lung cancer risk and response to platinum-based chemotherapy in non-small cell lung cancer (NSCLC) patients.
Gautschi O; Hugli B; Ziegler A; Bigosch C; Bowers NL; Ratschiller D; Jermann M; Stahel RA; Heighway J; Betticher DC
Lung Cancer; 2006 Mar; 51(3):303-11. PubMed ID: 16406195
[TBL] [Abstract][Full Text] [Related]
20. Effect of the CCND1 A870G polymorphism on prostate cancer risk: a meta-analysis of 3,820 cases and 3,825 controls.
Zheng M; Wan L; He X; Qi X; Liu F; Zhang DH
World J Surg Oncol; 2015 Feb; 13():55. PubMed ID: 25888980
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]